Showing results (81-90 of 357) with videos related to

Sort By:
Pageof 36
Transplantation and Cellular Therapy|January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell TransplantationOren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Leukemia & Lymphoma|January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantationAsad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide MaintenanceOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
American Journal of Hematology|October 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center StudyOren Pasvolsky, Shai Shimony, Rima M Saliba, et al.
Bone Marrow Transplantation|December 5, 2025
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myelomaOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
JCO Oncology Practice|January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Seminars in Oncology Nursing|October 11, 2021
The Unique Symptom Burden of Patients Receiving CAR T-Cell TherapyMeagan S Whisenant, Samer A Srour, Loretta A Williams, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical PracticeMark R Borgaonkar, David Pace, Muna Lougheed, et al.
Blood Advances|January 11, 2023
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor typeRohtesh S Mehta, David Marin, Amin Alousi, et al.
Cancer Research|April 29, 2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignanciesJeff K Davies, Harjeet Singh, Helen Huls, et al.
Pageof 36